Cystic Fibrosis Market, By Drug Class (Mucolytic {Mucoactive Drugs} and Bronchodilators, CFTR modulators, Antibiotics, Pancreatic Enzyme Replacement Therapy {PERT}), By Route of Administration (Oral, Inhalation), By Form (Powder, Liquid, Capsule, Tablet), By Distribution Channel (Offline {Hospital Pharmacies, Retail Pharmacies},Online Pharmacies ), by Region (United States, Canada, Mexico, France, The UK, Spain, Germany, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Brazil, Argentina, Rest of Latin America, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) — Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019–2027
Report ID :AMI-520 | Category : Healthcare | Published Date : March, 2020 | Pages : 402 | Format :PDF